[PepsiFree]

Originally Posted by JackIsBack

Lol.... I just check backed here.... I have no intention on educating the people here that belong to the educational dictatorship.

But... just so I understand, you, or the person you're quoting, are suggesting that someone who has "natural immunity" (not sure why it's in quotes - but just copying your style) where their immune system can recognize all 29 proteins on the COVID19 virus has inferior immunity to someone who has been vaccinated with the mRNA vaccine where there immune system can only recognize one (the spike protein) out of those 29 proteins and they have superior superior immunity. Give your head a shake.... so a hockey score of 29-1, the 1 wins in your world. When the COVID19 virus mutates (like in the delta strain)... all 29 proteins would have to change (be mutated) in order for the natural immunity to be completely ineffective, only one protein changing significantly would make the vaccine immunity ineffective... and guess what protein is different in the Delta strain... the spike protein?

I don't think we need to bash vaccines in general, but the mRNA vaccines have never worked widely in the real world before this one, it's a miracle. In the history of viruses.... and vaccines.... we have a vaccine that is better than natural immunity.... this has never occurred before in the history of vaccines... but continue your trek down the path of absurdity. I think if you're right, the pharmaceutical companies need to go back and redesign all the vaccines from chicken pox to measles, all the way down because if they are truly better - why can't we re-vaccinate the world here - and I can buy their stocks because you'll buy the vaccines - right?

Don't be afraid to learn something. Not only is your understanding of spike proteins and the way vaccines work completely off, but your conclusions are naturally off because of it.

A key issue as we move closer to ending the pandemic is determining more precisely how long people exposed to SARS-CoV-2, the COVID-19 virus, will make neutralizing antibodies against this dangerous coronavirus. Finding the answer is also potentially complicated with new SARS-CoV-2 “variants of concern” appearing around the world that could find ways to evade acquired immunity, increasing the chances of new outbreaks.

Now, a new NIH-supported study shows that the answer to this question will vary based on how an individual’s antibodies against SARS-CoV-2 were generated: over the course of a naturally acquired infection or from a COVID-19 vaccine. The new evidence shows that protective antibodies generated in response to an mRNA vaccine will target a broader range of SARS-CoV-2 variants carrying “single letter” changes in a key portion of their spike protein compared to antibodies acquired from an infection.

These results add to evidence that people with acquired immunity may have differing levels of protection to emerging SARS-CoV-2 variants. More importantly, the data provide further documentation that those who’ve had and recovered from a COVID-19 infection still stand to benefit from getting vaccinated.

https://directorsblog.nih.gov/2021/0...-an-infection/